BRKR240920C110000
- 1.90
- 0.000.00%
Bruker Corp Newsroom
Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software With Leading Provider of Mass Spectrometry Systems
Is Bruker Corporation (NASDAQ:BRKR) A High Quality Stock To Own?
Goldman's 'Goldilocks' Mid-cap Picks That Trade at Reasonable Valuations
Here's Why Bruker Corporation (BRKR) Fell in Q2
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Maintains Target Price $85
Jefferies analyst Tycho Peterson maintains $Bruker Corp(BRKR.US)$ with a buy rating, and maintains the target price at $85.According to TipRanks data, the analyst has a success rate of 57.9% and a
Biognosys Announces Commercial Availability of NULISA Proteomics Assay Services for Biomarker Research
Bruker Corp To Go Ex-Dividend On August 30th, 2024 With 0.05 USD Dividend Per Share
August 28th (Eastern Time) - $Bruker Corp(BRKR.US)$ is trading ex-dividend on August 30th, 2024.Shareholders of record on September 2nd, 2024 will receive 0.05 USD dividend per share on September 16
At US$63.95, Is It Time To Put Bruker Corporation (NASDAQ:BRKR) On Your Watch List?
Jefferies Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $78
Jefferies analyst Brandon Couillard maintains $Bruker Corp(BRKR.US)$ with a buy rating, and adjusts the target price from $85 to $78.According to TipRanks data, the analyst has a success rate of 64.0%
Bruker Price Target Announced at $78.00/Share by Wells Fargo
Bruker Initiated at Overweight by Wells Fargo
Wells Fargo Initiates Coverage On Bruker With Overweight Rating, Announces Price Target of $78
Bruker Corporation to Present at Upcoming Investor Conferences
Brookfield Asset Management (BAM.US) is seeking financing of nearly 10 billion euros to privatize Grifols.
According to sources, brookfield asset management (BAM.US) is requesting banks to provide up to 9.5 billion euros (equivalent to 10.6 billion US dollars) in debt support for its potential trade privatizing the Spanish pharmaceutical company Grifols SA.
TD Cowen Maintains Bruker Corp(BRKR.US) With Hold Rating, Maintains Target Price $72
TD Cowen analyst Daniel Brennan maintains $Bruker Corp(BRKR.US)$ with a hold rating, and maintains the target price at $72.According to TipRanks data, the analyst has a success rate of 53.6% and a
Bruker's (NASDAQ:BRKR) Solid Earnings May Rest On Weak Foundations
Bruker Announces Successful Installation of 1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute (KBSI)
Bruker Keeps Quarterly Dividend at $0.05 a Share, Payable Sept. 16 to Stockholders of Record Sept. 2
Should You Consider Adding Bruker Corporation (BRKR)?
Bruker Declares $0.05 Dividend